Edina Cenko: Looking Beyond the Epicardial Coronary Arteries
Edina Cenko, Chairperson of ESC Working Group on Coronary Pathophysiology and Microcirculation, posted on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Cardiology, adding:
“For decades, ischemic heart disease has been viewed mainly through the lens of epicardial coronary arteries.
However, growing evidence shows that the coronary microcirculation is a key determinant of symptoms, prognosis, and outcomes.
Why does this matter in clinical practice?
Patients with INOCA, and many patients after acute coronary syndromes, may have significant CMD that remains undetected if we focus only on angiography.
Identifying CMD can improve risk stratification and support more personalized management.
This systematic review and meta-analysis of 31 studies including more than 13,000 patients showed that invasively diagnosed CMD is associated with:
- 2.5-fold higher risk of MACE
- Nearly 3-fold higher risk of cardiovascular mortality
- Increased risk of myocardial infarction, heart failure hospitalization, and stroke
Patients with structural CMD (abnormal CFR and IMR) showed the highest risk, highlighting the importance of phenotyping CMD rather than considering it a single condition.
The message is clear: to fully understand ischemic heart disease, we must look beyond the epicardial arteries and consider the entire coronary circulation.
Congratulations to Konstantinos Kyriakoulis and the entire team for this important contribution to the field of coronary microvascular disease.”
Title: Prognostic effect of invasively diagnosed coronary microvascular dysfunction: A systematic review and META-analysis
Authors: Konstantinos G. Kyriakoulis, Kyriakos Dimitriadis, Athanasios Sakalidis, Nikolaos Pyrpyris, Eleni Adamopoulou, Stergios Soulaidopoulos, Panagiotis Tsioufis, Ioannis Doundoulakis, Angelos Papanikolaou, Konstantinos Aznaouridis, Petros Galanis, Natalija R. Odanovic, Ivan Ilic, Elmir Omerovic, Edina Cenko, Konstantinos Tsioufis

Stay updated with Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden